Post by Moderna on X
Moderna@moderna_tx
XToday we announced that the U.S. Food and Drug Administration has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.
This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological

197 likes0 repliesPosted Aug 6, 2026